Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 1 mg/72 timmar, depåplåster |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 0,25 %, ögondroppar |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 0,125 %, ögondroppar |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 0,5 %, ögondroppar |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 150 microgram oral tablet |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Hyoscine hydrobromide adverse reaction |
Causative agent |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
allergi mot skopolaminhydrobromid |
Causative agent |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Scopolamine hydrobromide 0.25% solution |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 400 microgram oral tablet |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
atropinsulfat + hyoscyaminsulfat + skopolaminhydrobromid |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 1 mg/72 timmar, depåplåster |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
papaveretum + skopolaminhydrobromid |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Hyoscine hydrobromide 150 microgram oral tablet |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Hyoscine hydrobromide [central nervous system use] |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|
Hyoscine hydrobromide [anesthesia] |
Is a |
False |
Scopolamine hydrobromide |
Inferred relationship |
Some |
|